[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Thirty-Day Readmission in Patients With Brain Cancer and Venous Thromboembolism: A Nationwide Analysis Using the National Readmissions Database",
    "section": "",
    "text": "Reference Studies:\n\nMallick et al., 2022\nJarvis et al., 2020\n\nStudy Objective:\nTo identify patient and hospital-level predictors of 30-day all-cause hospital readmission among adults hospitalized with brain cancer and Venous thromboembolism (VTE) using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nPrincipal or a secondary diagnosis of Brain cancer and VTE, identified using ICD-10-CM codes for BC (isBC pattern, including C710, C711, C712, C713, C714, C715, C716, C717, C718, C719, C7931) and VTE (isVTE pattern, including I2602, I2609, I2692, I2693, I2694, I2699, I82210, I82220, I82290, I823, I82401, I82402, I82403, I82409, I82411, I82412, I82413, I82419, I82421, I82422, I82423, I82429, I82431, I82432, I82433, I82439, I82441, I82442, I82443, I82449, I82451, I82452, I82453, I82459, I82461, I82462, I82463, I82469, I82491, I82492, I82493, I82499, I824Y1, I824Y2, I824Y3, I824Y9, I824Z1, I824Z2, I824Z3, I824Z9, I82601, I82602, I82603, I82609, I82611, I82612, I82613, I82619, I82621, I82622, I82623, I82629, I82A11, I82A12, I82A13, I82A19, I82B11, I82B12, I82B13, I82B19, I82C11, I82C12, I82C13, I82C19, I82811, I82812, I82813, I82819, I82890, I8290)\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nBinary indicator of 30-day readmission (Yes/No)\n\nSecondary Outcomes:\n\nIn-hospital mortality (binary)\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using NRD’s linkage variables. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid planned or injury-related returns unrelated to BC and VTE hospitalizations.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCost:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nZIP-based median income quartile (ZIPINC_QRTL)\nWeekend admission (AWEEKEND)\n\nClinical Characteristics:\n\nStandard comorbidities (from Elixhauser Index), using binary indicators:\nAnemia\nCongestive heart failure\nChronic pulmonary disease\nDiabetes mellitus\nHypertension\nRenal failure\nLiver disease\nObesity\n\nAdditional clinical risk factors (non-Elixhauser)\n\nPrevious stroke\nAcute myocardial infarction\nSmoking\nHyperlipidemia\nAtrial Fibrillation\n\nAcute complications identified via ICD-10 code matching:\n\nHemorrhage (Intracerebral and Subarachnoid)\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nNon-home discharge (e.g., SNF, hospice, other facilities, or death)\nLength of stay (categorized as above)\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design using discharge weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD) via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by 30-day readmission status to compare patients who were readmitted versus those who were not.\nStratification was performed using a derived binary variable, which categorized patients as:\n\nWith 30-day readmission\nWithout readmission\n\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nReference levels were explicitly set (e.g., Male, LOS ≤4 days).\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware:\nAll analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Thirty-Day Readmission in Patients With Brain Cancer and Venous Thromboembolism: A Nationwide Analysis Using the National Readmissions Database",
    "section": "",
    "text": "Reference Studies:\n\nMallick et al., 2022\nJarvis et al., 2020\n\nStudy Objective:\nTo identify patient and hospital-level predictors of 30-day all-cause hospital readmission among adults hospitalized with brain cancer and Venous thromboembolism (VTE) using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nPrincipal or a secondary diagnosis of Brain cancer and VTE, identified using ICD-10-CM codes for BC (isBC pattern, including C710, C711, C712, C713, C714, C715, C716, C717, C718, C719, C7931) and VTE (isVTE pattern, including I2602, I2609, I2692, I2693, I2694, I2699, I82210, I82220, I82290, I823, I82401, I82402, I82403, I82409, I82411, I82412, I82413, I82419, I82421, I82422, I82423, I82429, I82431, I82432, I82433, I82439, I82441, I82442, I82443, I82449, I82451, I82452, I82453, I82459, I82461, I82462, I82463, I82469, I82491, I82492, I82493, I82499, I824Y1, I824Y2, I824Y3, I824Y9, I824Z1, I824Z2, I824Z3, I824Z9, I82601, I82602, I82603, I82609, I82611, I82612, I82613, I82619, I82621, I82622, I82623, I82629, I82A11, I82A12, I82A13, I82A19, I82B11, I82B12, I82B13, I82B19, I82C11, I82C12, I82C13, I82C19, I82811, I82812, I82813, I82819, I82890, I8290)\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nBinary indicator of 30-day readmission (Yes/No)\n\nSecondary Outcomes:\n\nIn-hospital mortality (binary)\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using NRD’s linkage variables. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid planned or injury-related returns unrelated to BC and VTE hospitalizations.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCost:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nZIP-based median income quartile (ZIPINC_QRTL)\nWeekend admission (AWEEKEND)\n\nClinical Characteristics:\n\nStandard comorbidities (from Elixhauser Index), using binary indicators:\nAnemia\nCongestive heart failure\nChronic pulmonary disease\nDiabetes mellitus\nHypertension\nRenal failure\nLiver disease\nObesity\n\nAdditional clinical risk factors (non-Elixhauser)\n\nPrevious stroke\nAcute myocardial infarction\nSmoking\nHyperlipidemia\nAtrial Fibrillation\n\nAcute complications identified via ICD-10 code matching:\n\nHemorrhage (Intracerebral and Subarachnoid)\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nNon-home discharge (e.g., SNF, hospice, other facilities, or death)\nLength of stay (categorized as above)\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design using discharge weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD) via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by 30-day readmission status to compare patients who were readmitted versus those who were not.\nStratification was performed using a derived binary variable, which categorized patients as:\n\nWith 30-day readmission\nWithout readmission\n\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nReference levels were explicitly set (e.g., Male, LOS ≤4 days).\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware:\nAll analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#descriptive-statistics",
    "href": "quarto/index.html#descriptive-statistics",
    "title": "Thirty-Day Readmission in Patients With Brain Cancer and Venous Thromboembolism: A Nationwide Analysis Using the National Readmissions Database",
    "section": "Descriptive Statistics:",
    "text": "Descriptive Statistics:\n\nReadmission Rate:\nIndex hospitalizations resulted in:\n\nReadmission (n): 3515\nReadmission Rate (%): 16.22%\nReadmission Rate (95% CI): 15.4% to 17.05%\n\n\n\nIn-Hospital Mortality by Readmission Status:\nIndex hospitalizations resulted in:\n\nDeaths (n): 3033\nDeath Rate (%): 14.02%\nDeath Rate (95% CI): 13.27% to 14.76%\n\nReadmission hospitalizations resulted in:\n\nDeaths (n): 522\nDeath Rate (%): 14.98%\nDeath Rate (95% CI): 13.28% to 16.68%\n\n\n\nLOS and Cost by Readmission Status:\n\n\nIndex Hospitalizations\n\nMedian Length of Stay (IQR), days: 6 (IQR: 3–11)\nMedian Total Charges (IQR): $53,709 (IQR: $27,645–$115,391)\n\n\n\n\nReadmission Hospitalizations\n\nMedian Length of Stay (IQR), days: 4 (IQR: 2–7)\nMedian Total Charges (IQR): $36,305 (IQR: $19,815–$68,287)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Thirty-Day Readmission in Patients With Brain Cancer and Venous Thromboembolism: A Nationwide Analysis Using the National Readmissions Database",
    "section": "Baseline table:",
    "text": "Baseline table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout Readmission\nN = 18,1531\nWith 30-day readmission\nN = 3,5161\np-value2\nOverall\nN = 21,6691\n\n\n\n\nAge (years)\n63 (12)\n61 (12)\n&lt;0.001\n62 (12)\n\n\nSex\n\n\n\n\n0.3\n\n\n\n\n    Male\n9,093 (50%)\n1,715 (49%)\n\n\n10,808 (50%)\n\n\n    Female\n9,060 (50%)\n1,801 (51%)\n\n\n10,861 (50%)\n\n\nMedian Income Quartile\n\n\n\n\n0.019\n\n\n\n\n    0-25th percentile\n4,363 (24%)\n971 (28%)\n\n\n5,334 (25%)\n\n\n    26th to 50th percentile\n4,734 (26%)\n820 (24%)\n\n\n5,554 (26%)\n\n\n    51st to 75th percentile\n4,467 (25%)\n841 (24%)\n\n\n5,308 (25%)\n\n\n    76th to 100th percentile\n4,369 (24%)\n844 (24%)\n\n\n5,213 (24%)\n\n\nAdmission day\n\n\n\n\n0.010\n\n\n\n\n    Monday-Friday\n14,384 (79%)\n2,677 (76%)\n\n\n17,061 (79%)\n\n\n    Saturday-Sunday\n3,769 (21%)\n839 (24%)\n\n\n4,608 (21%)\n\n\nHospital Bed Size\n\n\n\n\n0.6\n\n\n\n\n    Small\n2,099 (12%)\n375 (11%)\n\n\n2,474 (11%)\n\n\n    Large\n11,906 (66%)\n2,329 (66%)\n\n\n14,235 (66%)\n\n\n    Medium\n4,148 (23%)\n811 (23%)\n\n\n4,959 (23%)\n\n\nTeaching Status\n\n\n\n\n0.046\n\n\n\n\n    Metropolitan, non-teaching\n3,215 (18%)\n600 (17%)\n\n\n3,815 (18%)\n\n\n    Metropolitan, teaching\n14,070 (78%)\n2,797 (80%)\n\n\n16,867 (78%)\n\n\n    Non-metropolitan\n868 (4.8%)\n118 (3.4%)\n\n\n986 (4.6%)\n\n\nChronic pulmonary disease\n4,595 (25%)\n988 (28%)\n0.032\n5,583 (26%)\n\n\nLiver disease\n738 (4.1%)\n134 (3.8%)\n0.7\n873 (4.0%)\n\n\nNon-home discharge\n8,122 (45%)\n884 (25%)\n&lt;0.001\n9,006 (42%)\n\n\nDiabetes mellitus\n3,910 (22%)\n796 (23%)\n0.3\n4,706 (22%)\n\n\nAnemia\n6,878 (38%)\n1,317 (37%)\n0.7\n8,195 (38%)\n\n\nHypertension\n8,059 (44%)\n1,637 (47%)\n0.12\n9,697 (45%)\n\n\nCongestive heart failure\n1,653 (9.1%)\n362 (10%)\n0.2\n2,014 (9.3%)\n\n\nAcute myocardial infarction\n445 (2.5%)\n60 (1.7%)\n0.060\n505 (2.3%)\n\n\nPrevious stroke\n1,174 (6.5%)\n241 (6.9%)\n0.5\n1,415 (6.5%)\n\n\nAtrial fibrillation\n2,149 (12%)\n369 (10%)\n0.2\n2,518 (12%)\n\n\nEnd-stage renal disease\n97 (0.5%)\n13 (0.4%)\n0.3\n109 (0.5%)\n\n\nCurrent or past smoking history\n1,895 (10%)\n390 (11%)\n0.4\n2,285 (11%)\n\n\nObesity\n1,775 (9.8%)\n389 (11%)\n0.12\n2,164 (10.0%)\n\n\nHyperlipidemia\n5,006 (28%)\n1,008 (29%)\n0.4\n6,013 (28%)\n\n\nChronic kidney disease\n1,317 (7.3%)\n242 (6.9%)\n0.6\n1,559 (7.2%)\n\n\nHemorrhage subtype\n\n\n\n\n&gt;0.9\n\n\n\n\n    Intracerebral\n1,135 (94%)\n175 (94%)\n\n\n1,310 (94%)\n\n\n    Subarachnoid\n69 (5.7%)\n10 (5.6%)\n\n\n79 (5.7%)\n\n\nLength of stay category\n\n\n\n\n0.8\n\n\n\n\n    ≤4\n6,950 (38%)\n1,333 (38%)\n\n\n8,283 (38%)\n\n\n    &gt;4\n11,203 (62%)\n2,183 (62%)\n\n\n13,386 (62%)\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#multivariable-regression",
    "href": "quarto/index.html#multivariable-regression",
    "title": "Thirty-Day Readmission in Patients With Brain Cancer and Venous Thromboembolism: A Nationwide Analysis Using the National Readmissions Database",
    "section": "Multivariable Regression",
    "text": "Multivariable Regression\n\n30-Day Readmission:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nAge (years)\n0.99\n0.97, 1.01\n0.4\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.93\n0.56, 1.53\n0.8\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.65\n0.30, 1.37\n0.3\n\n\n    51st to 75th percentile\n0.84\n0.42, 1.65\n0.6\n\n\n    76th to 100th percentile\n1.21\n0.63, 2.35\n0.6\n\n\nAdmission day\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.10\n0.64, 1.89\n0.7\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n1.96\n0.72, 5.33\n0.2\n\n\n    Medium\n1.29\n0.41, 4.08\n0.7\n\n\nTeaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.89\n0.47, 1.70\n0.7\n\n\n    Non-metropolitan\n0.51\n0.04, 6.48\n0.6\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.38\n0.78, 2.44\n0.3\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.32, 3.03\n&gt;0.9\n\n\nNon-home discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.26, 0.65\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n0.73, 2.09\n0.4\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.40, 1.17\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.40\n0.87, 2.27\n0.2\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.44, 2.88\n0.8\n\n\nAcute myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.74\n0.66, 11.3\n0.2\n\n\nPrevious stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.53\n0.19, 1.53\n0.2\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.26\n0.59, 2.70\n0.6\n\n\nEnd-stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.27\n0.53, 52.9\n0.2\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n0.57, 2.70\n0.6\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.37\n0.59, 3.17\n0.5\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n0.57, 1.91\n0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.26\n0.46, 3.42\n0.7\n\n\nLength of stay category\n\n\n\n\n\n\n\n\n    ≤4\n—\n—\n\n\n\n\n    &gt;4\n1.44\n0.82, 2.51\n0.2\n\n\nHemorrhage subtype\n\n\n\n\n\n\n\n\n    Intracerebral\n—\n—\n\n\n\n\n    Subarachnoid\n1.13\n0.45, 2.80\n0.8\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  }
]